JY
NURO

Jeff Yass’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Jeff Yass’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-154
Closed -$5K – 10984
2019
Q2 		$5K Buy
+154
New +$9K ﹤0.01% 10107
2018
Q2 		– Sell
-730
Closed -$82K – 10619
2018
Q1 		$82K Buy
+730
New +$91.5K ﹤0.01% 8777

Other funds holding NURO

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RIA
Realta Investment Advisors Wilmington, Delaware $322M AUM 39.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFS
Orrstown Financial Services Harrisburg, Pennsylvania $674M AUM 23.23% 1-Year Est. Return
RC
Randolph Company Cincinnati, Ohio $1.19B AUM 38.92% 1-Year Est. Return

Jeff Yass's NURO Position: Q3 2019 in Review

Jeff Yass sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q3 2019, closing a stake of 154 shares — an estimated $5K sold.

Jeff Yass first reported a position in NURO in Q1 2018 and held it in 2 quarters. The position peaked at $82K in Q1 2018. 12 funds tracked by Wall St. Rank hold NURO as of Q3 2019.

  • Jeff Yass reported no remaining NeuroMetrix, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Jeff Yass sold 154 NeuroMetrix, Inc. Common Stock shares in Q3 2019, an estimated $5K.
  • Jeff Yass first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
  • Jeff Yass's NeuroMetrix, Inc. Common Stock position peaked at $82K in Q1 2018.
  • 12 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.